Obermatt
See Similar Stocks →

Sartorius

GER:SRT · DE0007165607
Life Sciences Tools & ServicesLarge

360

11
EV / EBIT18
Price / Owner Earnings1
Owner Earnings Yield39
Dividend Yield31
Price/Sales34
EV / Gross Profit35
Price/Book22
Return on Capital47
Cash Return on Capital39
Return on Equity54
EBIT Margin59
Gross Profitability43
Cash Conversion94
Accruals60
Owner Earnings Margin39
Sales growth61
Profit Growth73
Long-Term EPS Growth80
Owner Earnings Growth21
Reinvestment42
Price momentum67
Debt load12
Refinancing18
Debt Payback4
Liquidity36
Analyst ratings46
Opinion Changes50
Price Target Upside49
Market mood67
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sartorius generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryGermany
IndustryLife Sciences Tools & Services
SizeLarge
TypePublic Company
ExchangeXTRA
Founded1990
Employees5,008
Websitesartorius.com
ISINDE0007165607
Last UpdateApr 2, 2026
Indices
CDAX (Germany)MDAX (Germany)TecDAX (Germany)
Themes
Water PurificationIndustrial AutomationProcess AutomationHealth DiagnosticsBiomedical EngineeringBiotechnologyHealth CareManufacturingPharmaceutical

Description

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services. Business Segments The company operates through two primary business segments: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions This se…

Analysis

Hope premium

Sartorius Aktiengesellschaft carries what we call a hope premium: an average business trading at an ambitious price.

The price is expensive. You pay 348.1× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 46% yearly growth; analysts expect 20%. The market is pricing in far more than analysts expect: heroic expectations.

The trajectory is moderate and the balance sheet is fragile. The company scores 14/20 on our value-creation score: strong value creator.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
22
2023202420252026

All-time high

57

Sep 2025

All-time low

1

Mar 2026

Average rank

24

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
34
41
22
27
Price/Earnings
18
34
19
19
Price/Book
22
27
19
6
Dividend Yield
31
34
38
34
Value (overall)
33
42
25
25

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sartorius with its peers
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
AddLife
STO:ALIF B
83
CountrySweden
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Tecan Group
SWX:TECN
25
CountrySwitzerland
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Eurofins Scientific
PAR:ERF
27
CountryLuxembourg
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Sartorius Stedim
PAR:DIM
15
CountryGermany
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →